Manchester, New Hampshire-based Sequel currently offers twiist for type 1 diabetes, launching earlier this year. It shared ...

In its first earnings call, the newly independent diabetes tech firm said it was transforming its product portfolio, with ...

Investigational study marks Sequel’s first pivotal data in type 2 diabetes, the largest population on insulin therapy and one of the most under-served by automated insulin deliveryNEW ORLEANS, June 08 ...

The hospital knew that not taking medications as prescribed following discharge is one of the major drivers of readmissions, so it knew it needed a way to proactively manage this risk and improve its ...

Over the past decade, healthcare organizations (HCOs) have relied on radio frequency identification (RFID) solutions to assist with patient identification and monitoring, as well as asset tracking.

“Arrive Health has primarily been focused on point-of-care price transparency, so we’ve built a network that can deliver real-time, patient-specific, moment-in-time pricing around medication into EHR ...

Today, that spirit continues to be the driving force behind much of what the company does—and has spearheaded a thriving local med tech ecosystem. Kelly Wei, VP of corporate strategy and innovation at ...

April data and first quarter earnings reports show remarkable resilience in med tech, even as other sectors continue to suffer in response to tariffs and changing regulations. Not that tariffs proved ...

New Hampshire lawmakers are weighing a measure to funnel state funding to skilled nursing facilities that train employees as medication nursing assistants. The goal is to increase certifications for ...